The Heidelberg Diagnostic technology has been used over the past 39 years by Researchers and Pharmaceutical companies throughout the world. 

Some of the recognized Pharmaceutical companies are; Pfizer (Global Research and Development), Boehringer Ingelheim, Tap Pharmaceuticals, Bayer, Merck, Glaxo, SmithKline and Novo Nordisk (Denmark).

When a pharmaceutical company develops a new medication, they use the Heidelberg diagnostic system to perform pharmacokinetic studies to determine the activity of the medication on the human body. This is where, in many cases, the Heidelberg technology becomes a valuable research tool, in assuring the safety of a newly developed medication. These studies are use to determine bodily absorption, distribution, metabolism and excretion of drugs. Before testing newly developed medications on humans, many pharmaceutical companies test their products on animals. Tests on animals include the use of swine, dogs, monkeys, etc. As part of their approval process, the Food and Drug Administration (FDA) requires testing of many newly developed medications in humans before being approved for use in the open market.

Researchers in many medical teaching colleges and research facilities use the Heidelberg Diagnostic system for testing the side effects of drugs. They also monitor the body pH when testing new vaccines to counter the effect of contagious diseases.

The Pharmaceutical Grade Heidelberg Diagnostic system can be configured to test from 1 to 8 subjects at the same time without interaction. Custom built systems can be configured to test 16 or more subjects at the same time without interaction.

Our current Bibliography of research studies contains over 150 published studies, conducted by researchers, pharmaceutical companies, clinicians, medical teaching colleges and hospitals. A copy of these studies are available upon request.